Number Needed to Treat Analyses to Assess Clinical Outcomes in Patients With Relapsing-Remitting Multiple Sclerosis Treated With Alemtuzumab or Ocrelizumab
| Affiliation auteurs | !!!! Error affiliation !!!! |
| Titre | Number Needed to Treat Analyses to Assess Clinical Outcomes in Patients With Relapsing-Remitting Multiple Sclerosis Treated With Alemtuzumab or Ocrelizumab |
| Type de publication | Journal Article |
| Year of Publication | 2017 |
| Auteurs | Comi G, Alroughani R, Berkovich R, Limmroth V, Macdonell RAl, Moreau T, Wiendl H, van Wijmeersch B, Melanson M, Thangavelu K, Freedman MS, Boster A |
| Journal | NEUROLOGY |
| Volume | 88 |
| Date Published | APR 18 |
| Type of Article | Meeting Abstract |
| ISSN | 0028-3878 |